Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000903429 | SCV001047895 | benign | not provided | 2023-10-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002390890 | SCV002705399 | likely benign | Cardiovascular phenotype | 2022-05-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003330991 | SCV004038242 | likely benign | not specified | 2023-08-06 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000903429 | SCV004158474 | likely benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | ABCA1: BP4, BP7 |